ORAL ANTICOAGULANTS WITH DUAL VERSUS SINGLE ANTIPLATELET THERAPY IN PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION: AN UPDATED META-ANALYSIS

Combined use of dual antiplatelet therapy with oral anticoagulation (OAC) is required after coronary artery stenting or acute coronary syndromes (ACS). We performed a meta-analysis (EMBASE and MEDLINE search) of the comparative effects of triple antithrombotic therapy (TT) vs OAC with single